- Home
- BXSL vs FOLD Comparison
BXSL vs FOLD Comparison
Compare BXSL & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXSL | FOLD |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | 499 |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.5B |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BXSL | FOLD |
|---|---|---|
| Price | $24.25 | $14.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $28.00 | $27.25 |
| AVG Volume (30 Days) | 2.7M | ★ 4.2M |
| Earning Date | 05-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 12.90% | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ 2.46 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.91 | $20.55 |
| Revenue Next Year | N/A | $18.34 |
| P/E Ratio | $9.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.31 | $5.66 |
| 52 Week High | $33.73 | $14.38 |
Technical Indicators
Market Signals| Indicator | BXSL | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 73.35 |
| Support Level | $24.17 | $14.21 |
| Resistance Level | $27.04 | $14.37 |
| Average True Range (ATR) | 0.64 | 0.04 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 38.26 | 93.75 |
Price Performance
Historical ComparisonAbout BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.